---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-091693"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T12:41:36.996330+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# TuHURA completes Kineta acquisition, adds Phase 2 VISTA mAb TBS-2025

## Summary
- Each Kineta share converted into 0.185298 TuHURA shares; ~2.87M shares issued at closing, plus up to ~1.13M additional shares subject to six-month adjustment.
- VISTA-inhibiting antibody renamed TBS-2025; TuHURA plans Phase 2 trial in NPM1 mutated AML in 2H 2025.
- Acquisition unlocks fourth tranche of $12.5M PIPE financing announced June 3, 2025.
- TuHURA believes TBS-2025 can overcome acquired resistance to cancer immunotherapy; exploring ADC synergies.

## SEC filing metadata
- accession: 0000950170-25-091693
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000095017025091693/0000950170-25-091693-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000095017025091693/hura-20250630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-091693
- JSON: https://secwatch.observer/filing/0000950170-25-091693.json
- Plain text: https://secwatch.observer/filing/0000950170-25-091693.txt

## Key facts
- M&A Transactions
  TuHURA Biosciences, Inc./NV completed an acquisition involving Kineta, Inc. for 0.185298 shares of TuHURA common stock per share, for an aggregate of approximately 2,868,169 shares of TuHURA Common Stock (closed 2025-06-30).
  - Action: acquisition
  - Counterparty: Kineta, Inc.
  - Consideration: 0.185298 shares of TuHURA common stock per share, for an aggregate of approximately 2,868,169 shares of TuHURA Common Stock
  - Closing: 2025-06-30
  source text: share of Kineta common stock, par value $0.001 per share (each, a “Share”), issued and outstanding immediately prior to the First Merger, was converted into the right to receive 0.185298 shares of TuHURA common stock, par value $0.001 per share (“TuHURA Common Stock”), for an aggregate of approximately 2,868,169 shares of TuHURA Common Stock. Also pursuant to the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000095017025091693/0000950170-25-091693-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.